Huveaux PLC
03 January 2006
3 January 2006
HUVEAUX PLC
Notification of Director's Share Interest
As announced on 25 November 2005, Dan O'Brien has been appointed Group Finance
Director effective 1 January 2006.
Dan O'Brien notified the Company on 3 January 2006, that he holds 2,500 Huveaux
PLC Ordinary shares of nominal value 10 pence each representing 0.002% of the
issued share capital.
Mr O'Brien also holds the following options over Ordinary shares under the
Company's Executive Share Option Scheme:
Grant Date Number of Options Exercise Price Exercise Period
17/11/05 200,000 £0.41 per share 17/11/08 - 16/11/15
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.